Advocacy intelligence hub — real-time data for patient organizations
Luveris: FDA approved
Luveris (lutropin alfa for injection), concomitantly administered with Gonal-f (follitropin alfa for injection), is indicated for stimulation of follicular development in infertile hypogonadotropic hypogonadal women with profound LH deficiency (LH (less than) 1.2 IU/L).
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Luveris
EMD Serono, Inc.
Luveris
(Recombinant human luteinizing hormone)Orphan drugEMD Serono, Inc.